From 17 to 20 November 2025, MEDICA will once again gather international experts from the medical industry in Düsseldorf, Germany. With over 5,000 exhibitors from 72 countries and 80,000 visitors MEDICA in Düsseldorf...
With increased complexity and nuance, the need for innovative copay and reimbursement strategies is now. Copay, Reimbursement and Access Congress is bringing together seasoned experts this November to deliver the...
Optimize Your Gross-To-Net Strategies to Drive Financial Excellence Save 10% today with VIP code: 25B4B10* The Pharma/Biotech GTN Summit, taking place November 18-20, 2025 in Philadelphia, PA, is a CPE accredited conference designed to equip pharmaceutical...
This congress is designed to help educate and share innovative program design, latest customer strategies and practical solutions to overcome complex barriers, enhance program performance and deliver best-in-class patient programs...
As the demand for plasmid DNA (pDNA) continues to surge across gene therapies, mRNA vaccines, and cell therapies, manufacturers are facing growing pressure to expand capacity with speed and precision....
We are very excited to announce our indoor Biotech Innovation & Vendor Expo at the Cambridge Marriott. Mark your calendars for a great opportunity to connect with industry leaders, explore...
Never has so much been at stake when it comes to investments in health care. All kinds of uncertainty — political, social, and scientific — stand between new preventatives, treatments,...
Selecting the right CRO is one of the most critical decisions in clinical development, yet rarely a straightforward one. Sponsors often find that comparing CRO proposals isn’t an apples-to-apples exercise...
Greater Philadelphia sits at the forefront of a dynamic life sciences evolution, where strategic decision-making today will shape the trajectory of the region’s biotech and innovation economy for years to...
What You'll Learn: How will lower interest rates influence biotech funding, investment flows, and real estate capital allocation in 2025? With a record volume of new lab and GMP supply...
AAV vectors offer clear benefits for gene therapy, and continued advances in technology have increased target specificity, improved potency, and intensified production efficiency. Even with significant attention early in development,...
Alzheimer’s disease is the most common cause of dementia. It is associated with the build-up of small protein aggregates in the brain, termed β-amyloid plaques, ultimately leading to brain damage...
